To evaluate the role of NTHL1 in breast cancer predisposition in diverse populations and independent studies, a total of 27,421 cases and 19,759 controls were screened for the entire coding region of NTHL1 from ten case–control studies including BEACCON as discovery dataset, and nine additional studies as validation dataset. This evidence concerns the gene NTHL1 and breast carcinoma.